| Item | Content |
|---|---|
| Rating | Neutral |
| Target Price | HKD 8.6–14.5 (base-case fair value range) |
| Current Price (Close) | HKD 13.94 (close of 2026-11-20; market cap approx. HKD 8.21 billion; 588.9 million total shares) |
| Margin of Safety | None: -38% based on the base-case fair value floor (current price is approx. 21% above the midpoint of the base-case range) |
| Time Horizon | 12 months |
| Company | AXERA, AI vision/edge AI inference SoC design (fabless), listed on the HKEX on 2026-02-10 at an offer price of HKD 28.20 |
AXERA is a leading emerging domestic player in edge AI vision chips, with 2026H1 revenue of RMB 402 million, up +181.8% YoY, and gross margin rising from 20.0% to 29.0% — the direction of edge AI demand is genuine. However, three verification checks in this report lead to a cautious conclusion: First, the +181.8% growth mainly reflects a low base combined with the volume-and-price upcycle in security SoCs (peer SigmaStar's revenue rose +111% over the same period with gross margin jumping approx. 24pp); 2026H1 revenue was actually -4.0% QoQ vs. 2025H2, and edge AI plus smart mobility — the true second curve — accounted for only 14.1% of revenue. Second, high growth has come at the cost of accelerated cash burn (2026H1 operating cash flow of -RMB 1.131 billion, adjusted loss widening 69% YoY); if H2 collections and loss reduction fall short, a refinancing/dilution risk exists in 2027. Third, approx. 82% of shares unlock on 2027-02-09 (financial investors' freely sellable holdings are approx. 2.7x the public float). At HKD 13.94, the current price implies approx. 7.2x 2026E PS; back-solving requires net profit of RMB 230–350 million by 2028, above the RMB 70–170 million extrapolated from the current cost structure — the current price sits at the top of the base-case fair range (HKD 8.6–14.5). Odds are roughly symmetric, but downside events are clustered. Rating: Neutral: do not enter for now; await the two checkpoints of February 2027 lock-up expiry behavior and the FY2026 annual report.
In one sentence: The edge AI sector has tailwinds and the company's growth positioning is real, but over the next 12–18 months, the dual supply events of "the 2027-02-09 unlock plus a highly probable refinancing window" hang over the stock; the current price is broadly in line with probability-weighted fair value (approx. HKD 15.4 per this report's three-scenario analysis), with no margin of safety.
Evidence grade B; market state neutral; entry precondition: wait for evidence to land: ① Unlock behavior not yet observed — 483 million pre-IPO shares (82.0% of total share capital) become eligible on 2027-02-09, of which 87 million shares in the employee incentive platform are subject to 2–4 year vesting and 110 million shares held by the founder group are subject to control constraints; financial investors' truly sellable holdings are approx. 286 million shares, about 2.7x the public float (106 million shares); as of this report's date, no shareholder holding ≥5% has filed any intention to reduce. ② FY2026 annual report (expected late March 2027) not yet verified on H2 revenue QoQ, gross margin defense, inventory drawdown, and cash flow improvement — reaching RMB 970 million for the full year (the only sell-side forecast) requires H2 revenue of RMB 568 million, QoQ +35.5%. ③ Net cash of approx. RMB 1.089 billion (strict definition) looks tight against the 2026H1 free cash flow gap of RMB 1.379 billion per half-year burn rate. Primary price driver: cash burn rate and refinancing dilution (circuit-breaker level); second, unlock supply behavior; third, AX8860/AX8850 order conversion and gross margin ramp. Expectation gap: the only public sell-side coverage is BOCOM International, which is also the company's compliance adviser (a conflicted party; see the corporate information page of the 2026 interim report); its HKD 37 target price has not been followed by the market — a genuine consensus is absent, so the expectation gap can only be framed narratively: the current price has already prepaid the optimistic component of "gross margin ramping toward ~50%," but at roughly half the HKD 28.20 offer price and with only a ~16% premium to the median PS of 5 comparables, the market has not fully priced in a "tipping-point premium" either — the gap runs both ways, not one-sided. Validation catalysts: FY2026 annual report, named AX8860 orders (window 2026-12 to 2027-06), M97 design wins, the ADAS mandatory-standard timetable, and no-reduction commitments ahead of the unlock window; falsification conditions: a placement at a discount exceeding 15%, cash-and-equivalents falling below RMB 1.2 billion, gross margin below 26% for two consecutive periods, or FY2026 revenue below RMB 800 million (see tracking plan at the end).
Key evidence:
This report's counter-check: Of FY2025 full-year revenue of RMB 562 million, 2025H2 contributed RMB 419 million (H2/H1 = 2.93x, strong seasonality); 2026H1 revenue of RMB 402 million was -4.0% QoQ vs. 2025H2; the +181.8% YoY reading mainly reflects amplification by the low 2025H1 base. In terms of revenue mix, 84.8% still comes from terminal computing (security/consumer vision SoCs); the company's MD&A attributes growth to "continued industry upcycle and upstream cost increases driving product mix upgrading toward high-end and intelligent products" — mutually corroborating SigmaStar's simultaneous surge, indicating industry beta rather than company-specific edge AI alpha; the true second curve (edge AI 6.9% + smart mobility 7.2%) totals only 14.1%. Also note: industry data such as AI glasses shipments in 2026 projected at 5x the 2024 level (IDC) and +263% YoY in 2026H1 (Counterpoint) do not yet map directly to company revenue — AXERA's 2026 interim report discloses no AI glasses SoC products or customers; moreover, IDC's global smart glasses shipment growth in 2026Q2 has slowed to +35.3% YoY with China turning negative for the first time — industry momentum is not monotonically upward. The share and CAGR figures cited in the prospectus (e.g., 12.2% share in China edge AI inference chips; edge inference market 2024–2030 CAGR of 27.3%) all come from CIC (灼识咨询), paid for by the issuer, with no independent third-party cross-validation. If the FY2026 annual report shows H2 revenue turning positive QoQ, AX8860 wins named orders, and edge AI share rises, this thesis will be revised favorably.
Key evidence:
Balanced view of definitions and buffers: As of 2026-06-30, cash-and-equivalents were RMB 2.177 billion (cash RMB 1.971 billion + wealth management products RMB 207 million); interest-bearing bank borrowings were RMB 1.089 billion (of which RMB 890 million are non-current borrowings over one year), giving strict-definition net cash of RMB 1.089 billion; additionally there is a Chongqing Chuangyuan redemption liability of RMB 467 million (contingent, triggered if the subsidiary fails to complete a qualifying IPO on schedule or upon change of control). Coverage of rigid cash obligations within 12 months (current borrowings of RMB 199 million) is adequate, and approx. HKD 2.16 billion of unused IPO proceeds are available as planned through 2030 — "a 2027 refinancing is inevitable" is not a foregone conclusion. But annualized at the 2026H1 pace, net operating cash outflow of approx. RMB 2.26 billion vs. cash-and-equivalents of RMB 2.177 billion makes the key question whether the front-loaded working capital (inventory + prepayments totaling approx. RMB 1.27 billion) converts into collections in the H2 shipping season; if not, the probability of launching equity financing in 2027 rises significantly — raising HKD 1.5 billion at the current price would require issuing approx. 108 million new shares (approx. 15.4% of post-issue share capital; approx. 18% dilution to existing shareholders), or approx. 25% dilution if the stock falls to HKD 10. In addition, the share option scheme has a separate reserve of up to 10% of share capital (58.89 million shares) — a potential dilution source independent of refinancing.
Key evidence:
Back-solving from the current HKD 8.21 billion market cap (approx. RMB 7.0 billion): at a comparable-company steady-state PE of 20–30x, the current price requires 2028 net profit of RMB 230–350 million (a net margin of 6.2%–9.4% on BOCOM's 2028E revenue of RMB 3.73 billion, with gross margin climbing from 29% to 48%–52%); extrapolating instead from the current gross margin and cost structure (annualized R&D approx. RMB 1.03 billion + SG&A approx. RMB 410 million), first-year 2028 net profit would be only approx. RMB 70–170 million, with the possibility of another loss if revenue grows along a more conservative path. Base-case fair value is HKD 8.6–14.5, with the current price at the top of the range (approx. 21% premium to the midpoint). Sensitivity view: if 2026E revenue is only RMB 820 million (H2 flat QoQ), PS rises from 7.2x to 8.5x and the premium widens from 16% to 37% — denominator risk masked by a single sell-side forecast.
Key evidence:
Composition breakdown (estimated in this report from the shareholding arrangements in the 2026 interim report): the employee incentive platform's 87 million shares (14.77%) are restricted shares vesting 50%/25%/25% at the 2nd/3rd/4th anniversaries of grant, unsellable before vesting; the founder (Dr. QIU) group's 110 million shares (18.7%) face control and disclosure constraints on reductions; after exclusions, financial investors hold approx. 286 million shares, about 2.69x the public float (106 million shares from the IPO global offering). As of this report's date, HKEXnews shows no reduction filings or block transfers by any shareholder holding ≥5% — "can sell" does not mean "will sell"; the deep underwater position (offer price 28.20 vs. current 13.94) actually weakens the incentive for active selling. But average daily turnover over the past 10 days is only approx. HKD 7.11 million (approx. 0.09% of market cap), so any marginal supply/withdrawal is amplified; if no-reduction or extended lock-up commitments emerge before the unlock, this overhang factor is removed, constituting a positive catalyst.
Key evidence:
The peer gross margin anchor itself is highly volatile: SigmaStar's gross margin touched a five-year low of 34.3% in Dec 2025 and rebounded to 57.8% in 2026 on the industry price-up cycle, indicating that a substantial part of the gap between AXERA's 29.0% and peers reflects scale (SigmaStar's first-three-quarter revenue of RMB 4.575 billion vs. AXERA's approx. RMB 800–900 million for the full year) and cycle position; the cycle continues into 2027, upside momentum remains — the gross margin ramp is an "assumption to be validated," not a given. The company operates as a single operating segment and does not disclose segment gross margins; validation must await annual report segment supplements or earnings call disclosures. Smart mobility 2026H1 revenue of RMB 29.09 million / shipments of approx. 420,000 units implies an ASP of approx. RMB 69/unit — low-end L2 front-view/parking solutions; rising per-vehicle value depends on the M57 ramp and M97 (700+ TOPS) design wins.
| Metric (RMB) | FY2022 | FY2023 | FY2024 | FY2025 | 2025H1 | 2026H1 (latest period) |
|---|---|---|---|---|---|---|
| Revenue (RMB 100mn) | 0.50 | 2.30 | 4.73 | 5.62 | 1.43 | 4.02 |
| Revenue YoY | — | +358.1% | +105.5% | +18.8% | — | +181.8% |
| Net loss attributable to parent (RMB 100mn) | -6.12 | -7.53 | -8.61 | -11.49 | -5.36 | -5.82 |
| Adjusted net loss (Non-IFRS, RMB 100mn) | -4.44 | -5.42 | -6.28 | -6.35 | -3.19 | -5.40 |
| Gross margin | 25.9% | 25.7% | 21.0% | 21.6% | 20.0% | 29.0% |
| R&D expenses (RMB 100mn) | — | — | 5.89 | 5.96 | 2.85 | 5.16 (+81.0%) |
| Operating cash flow (RMB 100mn) | — | -4.60* | -5.98* | -6.80* | -3.06 | -11.31 |
| Free cash flow (RMB 100mn) | — | — | -6.44* | -10.40* | — | -13.79 |
| Cash + cash-like assets (RMB 100mn) | — | — | — | 9.46 | — | 21.77 (2026-06-30) |
| Interest-bearing debt (bank borrowings, RMB 100mn) | — | — | — | 3.28 (current) | — | 10.89 (current 1.99 + non-current 8.90) |
| Liabilities-to-assets ratio | — | — | — | 233.6% (incl. redemption liability of 7.09bn) | — | 33.2% |
Notes: *FY2023–FY2025 full-year operating cash flows are anchored to third-party database values (FCF = operating cash flow - capex); extraction from the annual report cash flow statements was not completed and not verified against the original text — for trend reference only; the 2025H1/2026H1 periods and balance sheet items are as disclosed in announcements. Net debt/EBITDA is meaningless during loss-making periods (negative EBITDA) and is omitted. Goodwill of RMB 908 million + intangible assets of RMB 944 million (2026-06-30) together account for 32.3% of total assets and 48.4% of net assets.
Drivers of metric changes (items with YoY ≥ ±20%, with company explanations): ① Revenue +181.8% — the company attributes it to simultaneous growth across three lines: terminal computing volume-price gains (+169.5%), edge AI (+251.9%, downward penetration of large-model inference), and smart mobility (+252.1%, concentrated design-win SOP mass production); ② Gross margin +9.0pp to 29.0% — "product mix optimization, forward-looking capacity deployment, and lean supply chain management; economies of scale achieved through stable delivery under tight supply"; ③ R&D expenses +81.0% — "increased spending on new chip designs for smart mobility and edge AI," including tape-out costs for multiple advanced-node SoCs; ④ Inventory +122% to RMB 729 million — the company did not separately explain inventory aging or write-down provisions, with the MD&A citing only forward-looking capacity deployment to secure delivery; prepayments for materials purchases of RMB 543 million (+145%) over the same period; ⑤ Capex rose from RMB 46 million to RMB 360 million (FY2025) — mainly IP licenses and software purchases (RMB 241 million of this in 2026H1); ⑥ Other net losses turned negative (-RMB 48 million) — FX losses of RMB 48 million on USD deposits due to USD/CNY depreciation; ⑦ Net assets swung from -RMB 4.808 billion to positive RMB 3.829 billion — IPO net proceeds of RMB 2.566 billion were booked, and the RMB 6.688 billion preferred share redemption liability was derecognized into equity on the listing date.
2026H1 revenue was RMB 402 million (+181.8%), of which terminal computing contributed RMB 341 million (+169.5%, 84.8% of total), smart automotive RMB 29 million (+252.1%), and edge AI RMB 28 million (+251.9%); gross margin was 29.0% (+9.0pp YoY). On losses: net loss attributable to shareholders was RMB 582 million (vs. RMB 536 million in 2025H1), and adjusted loss was RMB 540 million (vs. RMB 319 million in 2025H1, widening 69% YoY) — the doubling of revenue failed to narrow losses, with the core reasons being R&D expenses of RMB 516 million (+81.0%, including tape-out costs for 4 chips at advanced process nodes) and upfront working capital deployment. Cash flow is the most alarming figure this period: net operating cash outflow of RMB 1,131 million (vs. RMB 306 million in 2025H1), 1.64x the book loss, with inventory and prepayments together rising by approximately RMB 940 million net over the half-year. Shipments: approximately 420,000 smart automotive SoCs in 2026H1 (630,000 for full-year 2025), 24 new mass-production model design wins, 25 cooperating OEM brands (including 7 international/JV brands); the AX8860 (6nm, 256 TOPS, native FP4, 128GB LPDDR5X) was launched at the China International Industry Fair on 2026-10-15 and won a "China Chip" award in early November, with order conversion yet to be verified. Market reaction: the day after interim results disclosure (2026-08-10), the share price fell 8.72% to HKD 12.98, indicating the market's pricing has shifted from PS-ratio optimism to earnings and cash flow verification. On sell-side expectations, the only public coverage is from BOCOM International (a compliance adviser, a party with a conflict of interest), whose 2026–2028 revenue forecasts are RMB 970 million / 1.95 billion / 3.73 billion, with EBITDA expected to turn positive in 2027 — under its framework, the full-year RMB 970 million target requires H2 revenue of RMB 568 million, +35.5% QoQ, which is precisely the watershed for the annual report reconciliation; this report makes no market consensus judgment.
Business model overview: A fabless AI inference SoC design company with an asset-light structure, outsourcing wafer fabrication and packaging/testing; revenue is recognized one-time upon chip sales (no subscription/recurring revenue; technical services contributed only RMB 5 million in 2026H1, 1.3% of total). Core assets are the proprietary "Axera Yuan" NPU and "Axera Vision" AI-ISP dual IPs and toolchain; products target mid-to-high-end (≥1 TOPS) edge vision, extending into edge AI inference (AX8850/AX8860) and automotive-grade assisted driving (M55H/M57/M97). Nominal pricing power: the "volume-price double rise" in 2026H1 indicates short-term improvement in bargaining power, but gross margin was previously compressed from 25.9% to 21.0% during 2024–2025, so price competition history is real.
Cash content of earnings: Looking at the ratio of cash burn to book loss during the loss-making period — OCF/net loss was approximately 0.61/0.69/0.59 for FY2023–FY2025 (cash burn below book loss), but spiked to 1.64 in 2026H1 (cash outflow exceeding book loss for the first time); FCF gap/net loss attributable to shareholders was approximately 0.75/0.90 for FY2024–FY2025, reaching 2.37 in 2026H1 — i.e., every RMB 1 of book loss corresponds to RMB 2.4 of cash outflow, with working capital absorption (inventory +RMB 400.7 million, prepayments +RMB 403.9 million, together 2.9x the revenue increment) being the main cause. In the long run, the test of "converting book profits into cash" is not yet applicable (the company is unprofitable), but the current trajectory is cash burn accelerating with revenue expansion, not scale-driven dilution.
Looseness of adjusted earnings measures: The company's adjusted loss adds back share-based payments (FY2025 RMB 116 million, 20.6% of revenue; 2026H1 RMB 71 million) and changes in fair value of redemption liabilities in full — SBC is a recurring compensation cost, and even after add-backs the adjusted loss still widened 69% YoY, indicating core operating losses are expanding rather than narrowing; government grants (FY2025 other income -56.3%, mainly due to reduced grants) have also smoothed the financial statements. Measured on a basis excluding one-off items, adjusted losses for FY2022–FY2025 were -444/-542/-628/-635 million RMB, with a persistently deteriorating trend.
Return on capital and capex quality: With persistent losses and negative NOPAT, ROIC is meaningless (not available and not applicable). Capex in FY2025 was RMB 360 million (7.8x FY2024's RMB 46 million), mainly IP licenses and software (RMB 241 million in 2026H1); CapEx/D&A was 2.49x (FY2025) — this is growth investment (purchasing IP for new process-node products), and maintenance capex cannot be separated and is not disclosed by the company. Intangible asset amortization rose 129% YoY to RMB 117 million in 2026H1 and will continue to pressure gross margins.
Moats and red flags: Moat signals — proprietary dual IPs, five generations of commercialized SoCs, cumulative shipments exceeding 212 million units (as of the 2025 annual report), automotive-grade certifications and 25 OEM brands, and a record-high number of industrial/robotics design wins in 2026H1. Red flags — top-5 customer concentration (2022–first nine months of 2025) at an absolute high of 91.5%→85.4%→75.2%→75.0%, supplier concentration (top-5 purchases at 66.4%, largest at 22.2%, first nine months of 2025), inventory at 466 days (rough estimate on an annualized cost-of-sales basis), goodwill + intangible assets at 48.4% of net assets, and annualized net operating cash outflow of approximately RMB 2.26 billion.
Consistency between words and deeds: pragmatic, with all verifiable commitments delivered. ① The FY2025 results announcement committed to "driving M57 mass-production adoption, with the first mass-production vehicle model launching in March 2026" — 2026H1 smart driving revenue +252.1%, shipments of 420,000 units, 24 new mass-production design wins: delivered. ② The M97 timeline (tape-out in 2025-10 → first silicon点亮 back and lit up in early 2026) — silicon returned and lit up in 2026-01, debut at the auto show in 2026-04, M9 series launch in 2026-09: delivered. ③ The prospectus growth narrative (2022–2024 revenue CAGR of 206.8%) — the +181.8% pace continued in 2026H1. The company has no tradition of quantitative guidance (HK-listed convention), with no record of missed guidance, but this also means the reconciliation baseline can only rely on sell-side and self-built forecasts. Verdict: leaning pragmatic.
Shareholder friendliness: neutral, leaning dilutive. No dividends since listing (justifiable during the loss-making period); no cancellation-type buybacks, but on 2026-08-09 authorized the use of no more than RMB 70 million of internal funds by a trustee to purchase shares on-market within 12 months for share award purposes; from 2026-09-15 to 10-14, 2,519,200 shares (0.43%) were purchased at an average price of HKD 21.17, costing HKD 53.31 million, with the board explicitly stating the share price is "undervalued" — the current price is 34% below that average, indicating poor buy-in timing but conveying confidence in direction; the scale (remaining quota of approximately HKD 23 million) has limited capacity to hedge unlock-related selling pressure. On dilution: IPO issued 106 million shares (18.0% of post-issue share capital) + equity incentive reserve capped at 10% of share capital. Verdict: neutral, incentive-oriented.
Risk signals: No controlling shareholder (the founder group led by Dr. QIU as the largest single shareholder at 18.70%); related-party transactions are properly disclosed but substantial — OmniVision Group's related-party sales in 2026H1 were RMB 90 million (22.4% of revenue; OmniVision is also a cornerstone investor, holding dual customer/shareholder status), and purchases from Anhui Shenji of RMB 50 million; FY2025 included listing expenses of RMB 24 million. The pre-IPO financing trajectory (2024 Series B/C at approximately RMB 21.6–22.0 per share → IPO at HKD 28.20) shows a gap between primary market pricing and secondary market reality — not a management integrity issue, but a caution on valuation discipline.
| Business line | 2026H1 revenue share | 2026H1 YoY | FY2025 share / YoY | Business logic in one sentence |
|---|---|---|---|---|
| Terminal computing (AX615/AX620Q/AX630C Black-Light series; security + consumer vision) | 84.8% | +169.5% | 83.4% / +4.8% | Mid-to-high-end vision SoC volume-price double rise; main driver in an industry upcycle |
| Smart automotive (M55H/M57; in development M97/M95/cockpit) | 7.2% | +252.1% | 8.6% / +618.2% | Design-win-to-SOP model; volume window driven by mandatory national standards for assisted driving |
| Edge AI (AX8850/8830 and compute cards) | 6.9% | +251.9% | 7.8% / +134.6% | Edge large-model inference; 8850 natively supports transformers, AX8860 already launched |
| Others (technical services) | 1.1% | — | — | Negligible share |
The company reports as a single operating segment and does not disclose segment gross margins, so a "revenue share × gross margin" profit-driver calculation cannot be performed. From the company-level gross margin attribution (the FY2025 gross margin recovery was attributed to "increased contribution from high-margin smart automotive and edge computing products"), it can be inferred that automotive and edge AI gross margins are higher than terminal computing, representing a source of marginal improvement in gross margin structure, but quantification depends on supplementary annual report disclosures. The current revenue driver and growth driver are both terminal computing (84.8%); "the profit driver is more likely the higher-margin automotive/edge AI businesses" is currently only a directional inference. Cross-segment comparisons of gross margin differentials ≥10pp cannot be verified due to non-disclosure. This disclosure gap is itself one of the reasons for this report's "to be verified" characterization in C5.
Accounting red flags (pattern + severity + original text evidence):
Cross-period consistency:
Disclosure cycle note: The company listed in 2026-02; audited periods are FY2022–FY2024 (prospectus) + FY2025 (annual report), so cross-period consistency can be assessed, though the depth of analysis is limited by PDF parsing completeness (the full-year cash flow statement original could not be retrieved and has been noted in the table).
Current market data (close of 2026-11-20): Share price HK$13.94, total market cap HK$8.21 billion (approx. RMB 7.00 billion, at 1 CNY = 1.172543 HKD, 2026-11-21); PB approx. 2.0x (net assets attributable to parent of RMB 3.494 billion as of 2026-06-30), broadly in line with Horizon's 2.63x / Black Sesame's 2.05x, below SigmaStar's 6.97x / Rockchip's 14.28x; PS: 12.5x on FY2025 basis, 8.7x annualized on 2026H1, 7.2x on 2026E (BOCOM: RMB 970 million), 8.5x assuming flat H2 QoQ; EV approx. HK$6.93 billion (excluding strict net cash of HK$1.276 billion), EV/Sales (2026E) approx. 6.1x. Listed less than one year, so historical percentiles lack statistical significance (PE is negative; PB's ~8th percentile since listing is for reference only) — this company is in a high-growth investment phase, where mechanical PE percentiles do not apply; the valuation anchor is a growth-based framework (PS / forward PE / ramp-up modeling).
Peer comparison table (data as of 2026-11-20; A-shares/US stocks at local close):
| Company | Market Cap | Revenue & Growth | Gross Margin | PS (basis) | Core Differences vs. AXERA |
|---|---|---|---|---|---|
| AXERA 00600.HK | HK$8.21 bn | 2026H1 RMB 402 mn, +181.8% | 29.0% | 7.2x (2026E) / 8.7x (H1 annualized) | Vertical vision + edge inference + automotive-grade; unprofitable |
| Horizon Robotics 9660.HK | HK$49.5 bn | 2026H1 RMB 2.055 bn, +32.9% | 66.0% | 10.3x (H1 annualized) | Smart-driving domain control + full-stack licensing; high margin, still loss-making on adjusted basis |
| Rockchip 603893.SS | RMB 78.1 bn | 2026 first three quarters RMB 4.449 bn, +41.6% (net profit attributable RMB 1.332 bn) | 46.4% | 13.7x (TTM) | Platform AIoT leader, already profitable at scale (PE 49x) |
| SigmaStar 301536.SZ | RMB 32.2 bn | 2026 first three quarters RMB 4.575 bn, +111.2% (net profit attributable RMB 1.564 bn) | 57.8% | 6.0x (TTM, PE 19.3x) | Largest security IPC SoC shipments; anchor for AXERA's margin ramp target |
| Ambarella AMBA | ~US$2.60 bn | FY2026 (ending 2026-01) US$391 mn, +37.2% | ~59%–61% | 6.2x (TTM) | Global high-end benchmark, proving the margin ceiling of the design segment |
| Black Sesame 2533.HK | HK$3.46 bn | 2026H1 RMB 458 mn, +81.3% (loss RMB 770 mn) | 41.0% | 3.2x (H1 annualized) | HK-listed loss-making edge AI chip; reference for deep de-rating |
What expectations the market has already priced in: The current price requires 2028 net profit of RMB 230–350 million (back-solved using comparable steady-state PE of 20–30x; implying net margin of 6.2%–9.4% on 2028E revenue of RMB 3.73 bn, gross margin ramping from 29% to 48%–52%, and opex converging to approx. RMB 1.5 bn/year) — the current price requires the company to nearly double its gross margin within three years while controlling expenses, whereas the reality is a 29.0% gross margin in 2026H1 and an annualized adjusted loss of approx. RMB 1.08 bn. Extrapolating 2028 first-year net profit at the current cost structure yields only RMB 70–170 million (or -130 to +50 million under stricter expense assumptions). Conclusion: expectations are elevated but not bubble territory — the stock has already halved from its IPO price and trades at only a ~16% premium to the median PS of 5 comparables; the market has not awarded a full "inflection-point premium." This is pricing that has been partially de-bubbled but still prepays a ramp-up option.
Three-layer value (EPV): Asset value floor = net cash basis: conservative (further deducting Chongqing Chuangyuan's contingent redemption liability of RMB 467 mn) approx. HK$1.24/share; strict basis approx. HK$2.17/share; zero-growth EPV cannot be computed — the company has no normalizable positive cash flow (annualized R&D of approx. RMB 1.03 bn is growth investment that cannot be decomposed into sustainable cash flow at the current scale), so it is left blank honestly. Measured against the conservative floor, approx. 91% of the current price is consideration for the growth/ramp-up option (residual basis: current price vs. asset floor; not a systematic EPV approach since EPV is not computable). The company sits at the structural demand inflection for edge AI (see the quantified chain in the industry overview chapter); a high "growth option share" does not by itself constitute evidence of overvaluation — the valuation verdict is left to the ramp scenarios.
Three scenarios and odds (fair value ranges, HK$/share; probabilities are this report's judgment):
| Scenario | Probability | Fair Range | vs. Current Price | Key Drivers |
|---|---|---|---|---|
| Bear | 0.30 | 5.3–8.0 | -62% to -43% | Inflection falsified: revenue of only RMB 1.3/1.6 bn in 2027/2028 (CAGR falls to ~25%), gross margin stalls at 29%–32%, low-priced refinancing dilutes ~20%; valuation anchor = Black Sesame's current PS 3.2x → 2.0–3.0x × 2028E revenue (707 mn diluted shares) |
| Base | 0.45 | 8.6–14.5 | -38% to +4% | BOCOM path achieved at a discount: 2028 revenue RMB 3.0–3.4 bn (2026–28 CAGR ~84%), gross margin ramps to 45%–48%, 2029E net profit RMB 220–320 mn; exit PE 26–30x (anchor: discounted from SigmaStar TTM 19.3x at cyclical highs to Rockchip TTM 49x range, independent of the company's current multiple), 15% discount over 2 years |
| Bull | 0.25 | 25.3–40.2 | +81% to +188% | Inflection fully realized: AI glasses/Agent Box/robotics + automotive mandates ramp on three fronts, 2028 revenue RMB 4.2–4.5 bn, gross margin approaching 52%, 2029E net profit RMB 550–750 mn (net margin 13%–17%, upside vs. Rockchip's 29.9%); exit PE 30–35x, 14% discount over 2 years |
Probability-weighted midpoint approx. HK$15.4 (approx. +10% vs. current price) — odds roughly symmetric: the tail asymmetry between downside scenarios (-43% to -62%) and upside scenarios (+81% to +188%) is compensated by the bull-market option, but the current price carries no discount under the base-case path. External reference points: on the pessimistic side, no comparable sell-side target price exists (BOCOM International is the only covering firm market-wide and serves as compliance advisor); on the optimistic side, BOCOM International's HK$37 (2026-10-21, a conflicted party, cited for comparison only; this report's scenarios do not converge toward it).
In-house earnings forecasts (reconciliation anchor alongside sell-side):
| Period | This Report Revenue | This Report Net Profit (Adjusted/IFRS) | BOCOM International (Compliance Advisor) | Management Guidance |
|---|---|---|---|---|
| FY2026E | RMB 860 mn–1.02 bn (midpoint 940 mn) | Adjusted loss RMB 1.04–1.14 bn; attributable loss RMB 1.2–1.35 bn | RMB 970 mn; EBITDA not yet positive | No numeric guidance |
| FY2027E | RMB 1.6–2.0 bn (midpoint 1.8 bn) | Adjusted loss narrows to RMB 600–900 mn; attributable loss RMB 700 mn–1.0 bn | RMB 1.95 bn; EBITDA turns positive | No numeric guidance |
Key assumptions: terminal computing +90%–120% for the full year, edge AI up ~3–4x to RMB 90–120 mn, smart automotive +230%–300% to RMB 100–130 mn, gross margin 29%–31% (36%–42% in 2027), full-year R&D RMB 1.05–1.15 bn. This report's 2026E is ~3% below BOCOM's (more conservative on H2 ramp), and 2027E is ~8% lower.
Valuation conclusion: fair (broadly reasonable, at the upper end of the base-case range) — separate quality (sector positioning, No. 3 share, margin improvement trajectory) from price (PS premium of 16% over the peer median, elevated back-solved expectations, no margin of safety): buying at the current price effectively means exchanging a -38% base-case downside exposure for a bull-market option. The key drivers are the gross margin ramp and AX8860/automotive order realization, and the 2027 lock-up expiry and possible refinancing precede validation points on the timeline. Liquidity warning: average daily turnover over the past 30 days approx. HK$13.8 mn (~0.17% of market cap), past 10 days approx. HK$7.11 mn (~0.09%, below the 0.1% warning threshold); small free-float market cap (IPO offer tranche only approx. HK$1.5 bn), so institutional entry/exit entails significant impact costs.
1. Industry size and the demand-inflection chain. AXERA's niche lies at the intersection of global "vision edge AI inference chips + edge AI inference SoCs + automotive-grade ADAS SoCs." Size must be measured in tiers (source: CIC, the prospectus industry consultant — a paid third party; headline figures are limited to this source, with aggregator estimates used only for cross-reference): ① global "edge and endpoint AI inference chip" market: ~RMB 379.2 bn in 2024 → projected RMB 1,612.3 bn by 2030, CAGR 27.3% (broad basis covering phones/automotive/smart home/robotics/vision edge); ② global "mid-to-high-end (≥1 TOPS) vision edge AI inference chip" market: ~RMB 2.4 bn in 2024 → ~RMB 5.0 bn by 2030, CAGR 13.1% (the company's core track: narrow basis, small absolute size); ③ shipments: ~134 mn global vision edge AI inference chips in 2024 (34.8 mn mid-to-high-end, 26.0% share), China 56.1 mn → projected 105.4 mn by 2030 (CAGR 11.1%). Cross-reference (corroborative only, far broader basis, unverified): Fortune Business Insights estimates the global Edge AI SoC market at ~US$42.17 bn in 2025. Quantified chain of the structural demand inflection (this report judges it valid, supported by multiple independent data sources): driver variables — convergence of large-model distillation/MoE lightweighting with edge compute; agent-type applications (OpenClaw and Hermes Agent named in the interim report) make Agent Boxes, robots, AI glasses, and smart vehicles simultaneously new carriers of inference compute; unit usage — traditional vision SoCs <1 TOPS → mid-to-high-end threshold ≥1 TOPS → company's 8850 series at 72 TOPS → AX8860 at 256 TOPS + 128GB LPDDR5X, a single-chip compute jump of roughly two orders of magnitude vs. the prior generation; penetration ramp — mid-to-high-end shipment share 26.0% (2024) → 41.3% (2030E, CIC); AI glasses from ~2.7 mn units in 2024 → projected 13.6 mn in 2026 (IDC, 5x in two years), +263% YoY in 2026H1 (Counterpoint); robotic edge inference chip shipments CAGR 54.4% for 2024–2030 (CIC); company share — 12.2% of China's edge AI inference chips, ranked No. 3 (2024 shipments, CIC); edge AI revenue share 6.9% (2026H1), still small, in the early switching stage. Risk basis to weigh alongside: IDC data shows global smart glasses shipment growth decelerated to +35.3% YoY in 2026Q2 (Q1 was +130.1%), with China posting its first negative growth — the inflection slope is not monotonic.
2. Value chain and value distribution. Upstream: EDA/IP (generic IP outsourced; in-house NPU/AI-ISP as the core moat) → wafer foundry (the company relies mainly on mature nodes; on the industry side, SMIC's 2026Q3 utilization was 97.3% and Hua Hong is at full capacity mulling price hikes; TSMC/Samsung advanced nodes are de facto restricted for Chinese design houses) → packaging & testing → memory (memory price hikes in 2026 significantly lift BOM). Midstream: Fabless design — sharply divergent gross margins: Ambarella ~59%–61%, SigmaStar 57.8%, Rockchip 46.4%, Black Sesame 41.0%, AXERA 29.0% (2026H1): value is not evenly retained at the design stage; pricing power stratifies by scale/product-definition capability/ecosystem. AXERA has weak bargaining power both upstream (top five suppliers 66.4% of purchases) and downstream (top five customers 75% of revenue), so margin improvement depends on product-mix upgrading. Downstream: solution providers/equipment makers/operators/automotive Tier 1s and OEMs, with governments and city projects, enterprises, and consumers as end payers; 96.0% of the company's 2026H1 revenue came from mainland China. Distribution channel share is rising rapidly (distribution revenue: RMB 2.4 mn in 2022 → RMB 200 mn in 2024 → RMB 162 mn in the first nine months of 2025), with products becoming more standardized.
3. Supply-demand and competitive landscape. Three demand engines: recovery and mid-to-high-end upgrading in smart security (volume and price both rising); edge large-model deployment (Agent Box/AI glasses/robotics, 0→1); the ADAS mandate window (company's basis: regulation-driven products such as AEB to be installed in 50 mn vehicles annually over the next 3–5 years, ~12 mn in China; high-level combined ADAS CAGR of 28%/29% globally/China over the next three years). Supply side: dense designer landscape (Ambarella, Novatek, SigmaStar, Rockchip, Fullhan, Ingenic, AXERA, Horizon, Black Sesame), with new entrants generally loss-making (AXERA/Horizon/Black Sesame all unprofitable); the true bottleneck is upstream mature-node foundry and memory — tight-to-very-tight balance in 2026, with the company officially citing "demand exceeding supply" in H1. Concentration (CIC shipment basis, 2024): global vision edge AI inference chips — AXERA 9.124 mn units, 6.8% share, ranked No. 5, with the top tier relatively fragmented (CR3/CR5 on a unified basis unavailable); China edge AI inference chips — AXERA 12.2%, No. 3; China domestic smart-driving SoCs — No. 2 among domestic suppliers by 2024 installations. Entry barriers: R&D intensity (AXERA's 2026H1 R&D/revenue 128%), in-house IP and toolchain, automotive qualification cycles, capital requirements (cumulative losses exceeding RMB 2.2 bn in the three years pre-IPO). Price wars and substitution: frequent historical price wars in low-end security, which AXERA avoids via ≥1 TOPS positioning; substitution threats come from general-purpose AIoT SoC platforms moving down-market (Rockchip/MediaTek), downstream in-house vertical integration, and Ambarella's high-end solutions; the 2026 upcycle has paused price wars, but if conditions soften in 2027 with spec-down competition, price-war risk rises.
4. Cycle and regulation. The industry is in an upturn within its growth phase: low penetration (mid-to-high-end share 26%), edge large models at 0→1; leading indicators — mature-node foundry utilization and pricing (SMIC 97.3% + confirmed price hikes), memory prices, revenue acceleration of security SoC vendors (SigmaStar +111% over the first three quarters), quarterly AI glasses shipments, and the cadence of new edge product launches. Regulation/geopolitics is the largest exogenous variable: the US BIS rule of 2026-11-16 (blocking third-country remote access to advanced compute data centers) does not directly touch edge SoCs, but the 2026-05-31 "penetrating review of entities and control relationships" guidance shows the scope expanding along entity lines — if extended to edge AI chip foundry/EDA, there is tail risk for future tape-outs of the company's AX8850 (12nm)/AX8860 (6nm) (not yet occurred; low probability but high impact); conversely, it would strengthen domestic substitution and Xinchuang (IT innovation) procurement. On the China side: the mandatory national ADAS standard and localization procurement favor domestic share. FX exposure: USD fundraising deposits recorded an FX loss of RMB 48 mn in 2026H1.
5. Peer comparison: see the comparison table in the valuation chapter (revenue/growth/gross margin/PS/market cap/positioning differences all covered); the company's own same-basis data (2026H1 revenue RMB 402 mn, +181.8%, gross margin 29.0%, market cap HK$8.21 bn) is included in the same table. Key points: AXERA's revenue is roughly 1/8–1/11 of Rockchip's/SigmaStar's, but it leads on growth and compute positioning (256 TOPS FP4 product already launched); the gap vs. profitable peers represents the catch-up space in "gross margin × scale," while the gap vs. loss-making peers (Horizon/Black Sesame) lies in cash reserves and multi-scenario layout.
6. Company industry positioning: leading rising player in the domestic edge AI vision camp — No. 1 globally in mid-to-high-end (≥1 TOPS) vision edge AI inference chips (24.1% share), No. 5 globally in vision edge overall (6.8%), No. 3 in China edge AI inference (12.2%), No. 2 in domestic smart-driving SoCs (all on 2024 shipments, CIC basis). Basis disclosure: all the above shares and rankings come from CIC, paid by the issuer (prospectus industry consultant); no public verification of the company's share was found from independent third parties such as IDC/Omdia/Counterpoint — basis caveat: CIC ranks by "shipments" rather than "revenue"; AXERA's ASP is low (especially automotive at ~RMB 69/unit), so revenue-basis rankings would be significantly lower than shipment-basis rankings. Share trend: rising (shipment and revenue shares both up in 2026H1; the No. 1 mid-to-high-end and No. 3 edge AI positioning is further strengthening after the AX8860 launch); moat source = dual in-house IP plus mid-to-high-end product-definition capability, not scale or cost.
For fabless chip design, the decisive factors are not current-period P&L but product-generation cadence, design wins, and inventory management — these three determine revenue inflection points and impairment risk, which generic financial frameworks easily miss.
Product generations and shipments: Five generations of SoCs commercialized; cumulative terminal computing shipments exceeded 157 mn units (as of 2025-09-30); 2025 full-year SoC shipments of 86 mn units, cumulative over 212 mn units (note the basis: the prospectus's "93 mn AI inference SoC shipments in 2024" is a high-end subset basis, not comparable to total shipments — do not divide directly to derive ASP); smart automotive SoC shipments of 630k units in 2025 → ~420k units in 2026H1; 8850 series from 21k units in 2023 → 100k+ units in 2024. Tape-out cadence (right chip at the right time): M57 in mass production and riding a leading EV startup's models into Europe (Leapmotor, 2026-10); M97 (700+ TOPS, supporting VLA/world models) taped out 2025-10, dies returned and powered on 2026-01, M9 series officially launched 2026-09, engineering samples delivered in H1; M95 dies returned 2026-07; first cockpit large-model accelerator chip taped out; AX8860 (6nm) launched 2026-10-15. 2026H1 R&D expense includes tape-out fees for 4 advanced-node chips (one-off, roughly tens of millions to RMB 100 mn+ per chip); this is the main driver of the +81% R&D in 2026H1 and a potential source of R&D base decline in 2027. Design wins and customer adoption: 24 new mass-production vehicle design wins and 25 cooperating OEM brands in 2026H1 (including 7 international/JV brands), 25+ new design wins in 2025; edge AI side: industrial camera/robot/drone design wins at record highs; cumulative automotive chip shipments over 1.6 mn units (as of 2026-08). Media reports (Gasgoo, unverified) say the NIO camp is partnering with AXERA and OmniVision on the M97 and has approached Leapmotor/Geely — if true, this would significantly elevate the design-win tier, subject to company announcements. Inventory and stockpiling: inventory of RMB 729 mn (~466 days, on rough annualized COGS) plus prepayments for materials of RMB 543 mn, reflecting "forward stockpiling amid demand exceeding supply," consistent with the industry-wide strategic stockpiling by SigmaStar/Rockchip amid memory price hikes; the risk lies in the conversion rate of "stockpiling into revenue" — if AX8860/M97 adoption disappoints, the 466-day inventory is an impairment exposure. Channel structure: distribution share rising rapidly (RMB 200 mn in 2024), enabling standardized volume ramp but reducing end-demand visibility.
Overall judgment: Neutral, confidence 0.55, time horizon 12 months. AXERA has a genuine track positioning (No.1 in mid-to-high-end edge vision AI, No.3 in China edge AI inference — per CIC definitions) and gross margin improvement that is being validated (20%→29%), so the quantified chain of the industry demand inflection point holds. However, the company's own "edge AI second growth curve" is still small on the financial statements (14.1%), cash burn is accelerating (annualized operating net outflow of approximately RMB 2.26 billion vs. deemed cash of RMB 2.177 billion), and valuation has already pre-paid the optimistic path of gross margin doubling (current price carries a premium of approximately 21% over the midpoint of the base-case range, with no margin of safety). Moreover, the 2027-02-09 lock-up expiry and a possible 2027 refinancing fall ahead of key validation points (FY2026 annual report, AX8860 orders). Strategically, hold off on entry for now: wait for ① clarity on the lock-up expiry behavior (no-sell commitment or sale filing) and ② the FY2026 annual report (H2 sequential growth, gross margin holding its position, inventory drawdown, cash flow improvement) — two signals. If the stock price approaches the lower bound of the base-case range at HKD 8.6 without fundamental deterioration, the risk-reward ratio will improve significantly; if gross margin sustains above 40% for two consecutive periods and edge AI revenue share rises, upgrade toward the base/bull case. Risk warnings: low liquidity (10-day average daily turnover of approximately HKD 7.11 million, approximately 0.09% of market cap) combined with a small free float amplifies price volatility; entry and exit should be done in tranches. The main downside risks, in order, are dilution from a low-priced refinancing, lock-up expiry selling, inventory/goodwill impairment (goodwill + intangibles at 48.4% of net assets), and BIS control tail risk (advanced-process tape-outs of AX8850/8860). The main upside catalysts are a named AX8860 order, a designation from a leading automaker for the M97 project, finalization of the assisted-driving mandatory standard timetable, the Hang Seng TECH Index review in February 2027 (revenue growth cohort pathway), and incremental inflows from southbound/AI index ETFs.
Tracking arrangements: the next earnings disclosure is expected in late March 2027 (FY2026 annual results, statutory deadline 2027-03-31); core monitoring conditions (three price levels at HKD 14.5/9.85/8.6, annual report revenue and gross margin, placement announcements, lock-up expiry sale filings, BIS developments, etc.) have been set up as conditional automated tracking, with rating review triggered upon activation.
Data and definitions note: financial data as of 2026-06-30 (2026 interim report, reviewed by KPMG); price anchor is the 2026-11-20 close of HKD 13.94; exchange rate 1 CNY = 1.172543 HKD (2026-11-21). FY2023–FY2025 full-year operating cash flows are third-party anchored values not independently verified against source documents. Industry shares and CAGR are from CIC (paid consultant to the prospectus). Sell-side forecasts come from BOCOM International only (the company's compliance advisor, a party with a conflict of interest). Forecasts in this report are the report's own work, not company guidance.
<!-- publication:4f7f8d77b312f358a4aab3d4 -->